Assignee
ABRAXIS BIOSCIENCE LLC
US·56 granted patents·91 pending applications·1,673 citations·filing 2004–2025
Top patents by PatentIndex Score
147 records- 0199US9724323B2Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxaneABRAXIS BIOSCIENCE LLC·Filed 2015·Granted Aug 8, 2017·28 cites·57 claims
- 0299US8034375B2Combinations and modes of administration of therapeutic agents and combination therapyABRAXIS BIOSCIENCE LLC·Filed 2006·Granted Oct 11, 2011·149 cites·34 claims
- 0399US7923536B2Compositions and methods of delivery of pharmacological agentsABRAXIS BIOSCIENCE LLC·Filed 2010·Granted Apr 12, 2011·160 cites·16 claims
- 0499US7820788B2Compositions and methods of delivery of pharmacological agentsABRAXIS BIOSCIENCE LLC·Filed 2006·Granted Oct 26, 2010·211 cites·12 claims
- 0599US7758891B2Combinations and modes of administration of therapeutic agents and combination therapyABRAXIS BIOSCIENCE LLC·Filed 2008·Granted Jul 20, 2010·137 cites·18 claims
- 0698US11497737B2Pharmaceutical compositions of albumin and rapamycinABRAXIS BIOSCIENCE LLC·Filed 2020·Granted Nov 15, 2022·10 cites·30 claims
- 0798US9561288B2Combinations and modes of administration of therapeutic agents and combination therapyABRAXIS BIOSCIENCE LLC·Filed 2013·Granted Feb 7, 2017·29 cites·24 claims
- 0898US8999396B2Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxaneABRAXIS BIOSCIENCE LLC·Filed 2013·Granted Apr 7, 2015·38 cites·13 claims
- 0998US8846771B2Compositions and methods of delivery of pharmacological agentsABRAXIS BIOSCIENCE LLC·Filed 2012·Granted Sep 30, 2014·48 cites·12 claims
- 1098US7780984B2Methods and compositions for treating proliferative diseasesABRAXIS BIOSCIENCE LLC·Filed 2007·Granted Aug 24, 2010·66 cites·11 claims
- 1197US9295733B2SPARC binding ScFcsABRAXIS BIOSCIENCE LLC·Filed 2014·Granted Mar 29, 2016·35 cites·7 claims
- 1297US9012518B2Compositions and methods of delivery of pharmacological agentsABRAXIS BIOSCIENCE LLC·Filed 2013·Granted Apr 21, 2015·36 cites·21 claims
- 1397US9012519B2Compositions and methods of delivery of pharmacological agentsABRAXIS BIOSCIENCE LLC·Filed 2013·Granted Apr 21, 2015·38 cites·12 claims
- 1497US8034765B2Compositions and methods for preparation of poorly water soluble drugs with increased stabilityABRAXIS BIOSCIENCE LLC·Filed 2006·Granted Oct 11, 2011·116 cites·21 claims
- 1597US7981445B2Compositions and methods for preparation of poorly water soluble drugs with increased stabilityABRAXIS BIOSCIENCE LLC·Filed 2009·Granted Jul 19, 2011·73 cites·14 claims
- 1696US11320416B1Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drugABRAXIS BIOSCIENCE LLC·Filed 2020·Granted May 3, 2022·4 cites·43 claims
- 1796US9820949B2Methods of treatment of pancreatic cancerABRAXIS BIOSCIENCE LLC·Filed 2016·Granted Nov 21, 2017·22 cites·48 claims
- 1896US9597409B2Methods of treating cancerABRAXIS BIOSCIENCE LLC·Filed 2013·Granted Mar 21, 2017·25 cites·27 claims
- 1996US9511046B2Methods of treating pancreatic cancerABRAXIS BIOSCIENCE LLC·Filed 2013·Granted Dec 6, 2016·42 cites·34 claims
- 2096US9149455B2Methods of treating melanomaABRAXIS BIOSCIENCE LLC·Filed 2013·Granted Oct 6, 2015·43 cites·16 claims
- 2196US7858782B2Triazine derivatives and their therapeutical applicationsABRAXIS BIOSCIENCE LLC·Filed 2007·Granted Dec 28, 2010·54 cites·6 claims
- 2296US7771751B2Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agentsABRAXIS BIOSCIENCE LLC·Filed 2006·Granted Aug 10, 2010·81 cites·21 claims
- 2395US12061183B2Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drugABRAXIS BIOSCIENCE LLC·Filed 2022·Granted Aug 13, 2024·2 cites·18 claims
- 2495US10705070B1Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drugABRAXIS BIOSCIENCE LLC·Filed 2019·Granted Jul 7, 2020·8 cites·33 claims
- 2595US10682420B2Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxaneABRAXIS BIOSCIENCE LLC·Filed 2017·Granted Jun 16, 2020·6 cites·19 claims
- 2695US10527604B1Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxelABRAXIS BIOSCIENCE LLC·Filed 2016·Granted Jan 7, 2020·10 cites·32 claims
- 2795US10413531B2Methods of treating bladder cancerABRAXIS BIOSCIENCE LLC·Filed 2018·Granted Sep 17, 2019·12 cites·19 claims
- 2895US10076501B2Use of polymeric excipients for lyophilization or freezing of particlesABRAXIS BIOSCIENCE LLC·Filed 2017·Granted Sep 18, 2018·17 cites·46 claims
- 2995US9962373B2Methods of treating bladder cancerABRAXIS BIOSCIENCE LLC·Filed 2014·Granted May 8, 2018·19 cites·17 claims
- 3095US9585960B2Use of polymeric excipients for lyophilization or freezing of particlesABRAXIS BIOSCIENCE LLC·Filed 2012·Granted Mar 7, 2017·25 cites·20 claims
- 3195US9446003B2Prion free nanoparticle compositions and methods of making thereofABRAXIS BIOSCIENCE LLC·Filed 2014·Granted Sep 20, 2016·27 cites·10 claims
- 3295US9399072B2Methods of treatment of pancreatic cancerABRAXIS BIOSCIENCE LLC·Filed 2013·Granted Jul 26, 2016·24 cites·11 claims
- 3394US10973806B2Methods of treating epithelioid cell tumors comprising administering a composition comprising nanoparticles comprising an mTOR inhibitor and an albuminABRAXIS BIOSCIENCE LLC·Filed 2016·Granted Apr 13, 2021·6 cites·12 claims
- 3494US10555912B2Use of polymeric excipients for lyophilization or freezing of particlesABRAXIS BIOSCIENCE LLC·Filed 2018·Granted Feb 11, 2020·9 cites·46 claims
- 3594US9855220B2Methods of treating pancreatic cancerABRAXIS BIOSCIENCE LLC·Filed 2016·Granted Jan 2, 2018·18 cites·23 claims
- 3693US10328031B2Methods of treating pancreatic cancerABRAXIS BIOSCIENCE LLC·Filed 2017·Granted Jun 25, 2019·12 cites·17 claims
- 3792US11944708B2Methods of treating central nervous system disorders via administration of nanoparticles of an mTOR inhibitor and an albuminABRAXIS BIOSCIENCE LLC·Filed 2020·Granted Apr 2, 2024·4 cites·19 claims
- 3892US10900951B1Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxelABRAXIS BIOSCIENCE LLC·Filed 2019·Granted Jan 26, 2021·6 cites·25 claims
- 3992US10206887B2Prion free nanoparticle compositions and methods of making thereofABRAXIS BIOSCIENCE LLC·Filed 2016·Granted Feb 19, 2019·10 cites·21 claims
- 4091US10744110B2Methods of treating lung cancerABRAXIS BIOSCIENCE LLC·Filed 2014·Granted Aug 18, 2020·7 cites·12 claims
- 4191US2025186359A1Nanoparticle comprising rapamycin and albumin as anticancer agentABRAXIS BIOSCIENCE LLC·Filed 2024·Application pending·0 cites
- 4289US12324860B2Methods of treating central nervous system disorders via administration of nanoparticles of an mTOR inhibitor and an albuminABRAXIS BIOSCIENCE LLC·Filed 2024·Granted Jun 10, 2025·1 cites·20 claims
- 4385US2024065984A1Nanoparticle comprising rapamycin and albumin as anticancer agentABRAXIS BIOSCIENCE LLC·Filed 2023·Application pending·0 cites
- 4476US2021322335A1Nanoparticle comprising rapamycin and albumin as anticancer agentABRAXIS BIOSCIENCE LLC·Filed 2021·Application pending·0 cites
- 4575US2015050356A1Nanoparticle comprising rapamycin and albumin as anticancer agentABRAXIS BIOSCIENCE LLC·Filed 2014·Application pending·0 cites
- 4675US2023080409A1Biomarkers for nanoparticle compositionsABRAXIS BIOSCIENCE LLC·Filed 2022·Application pending·0 cites
- 4774US12133844B2Methods of treating epithelioid cell tumorsABRAXIS BIOSCIENCE LLC·Filed 2021·Granted Nov 5, 2024·0 cites·14 claims
- 4874US2024009323A1Methods of treating colon cancer using nanoparticle mtor inhibitor combination therapyABRAXIS BIOSCIENCE LLC·Filed 2023·Application pending·0 cites
- 4974US2019022020A1Nanoparticle comprising rapamycin and albumin as anticancer agentABRAXIS BIOSCIENCE LLC·Filed 2018·Application pending·0 cites
- 5073US2019343789A1Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agentsABRAXIS BIOSCIENCE LLC·Filed 2019·Application pending·0 cites
Showing the top 50 of 147 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →